Previous evidence has revealed that liver-specific knockout of SIRT6 significantly increases the proprotein convertase subtilisin/kexin type 9 (PCSK9) gene expression and plasma LDL-C levels, while SIRT6 overexpression improves lipid metabolism and reduces atherosclerosis risk by lowering plasma LDL-C and PCSK9 levels [26]. This evidence concerns the gene PCSK9 and atherosclerosis.